Christie Ballantyne , Szilard Vasas , Masoud Azizad , Peter Clifton , Robert Rosenson , Jennifer Hellawell , Ting Chang , Stacey Melquist , Ran Fu , Ma'An Muhsin , Javier San Martin , Daniel Gaudet
{"title":"Plozasiran (ARO-APOC3),可降低混合型血脂异常患者的 APOC3 和甘油三酯 (TG):MUIR 最终结果","authors":"Christie Ballantyne , Szilard Vasas , Masoud Azizad , Peter Clifton , Robert Rosenson , Jennifer Hellawell , Ting Chang , Stacey Melquist , Ran Fu , Ma'An Muhsin , Javier San Martin , Daniel Gaudet","doi":"10.1016/j.atherosclerosis.2024.118492","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":8623,"journal":{"name":"Atherosclerosis","volume":null,"pages":null},"PeriodicalIF":4.9000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Plozasiran (ARO-APOC3), decreases APOC3 and triglycerides (TG) in patients with mixed dyslipidemia: MUIR final results\",\"authors\":\"Christie Ballantyne , Szilard Vasas , Masoud Azizad , Peter Clifton , Robert Rosenson , Jennifer Hellawell , Ting Chang , Stacey Melquist , Ran Fu , Ma'An Muhsin , Javier San Martin , Daniel Gaudet\",\"doi\":\"10.1016/j.atherosclerosis.2024.118492\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":8623,\"journal\":{\"name\":\"Atherosclerosis\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Atherosclerosis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0021915024010591\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Atherosclerosis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0021915024010591","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
期刊介绍:
Atherosclerosis has an open access mirror journal Atherosclerosis: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review.
Atherosclerosis brings together, from all sources, papers concerned with investigation on atherosclerosis, its risk factors and clinical manifestations. Atherosclerosis covers basic and translational, clinical and population research approaches to arterial and vascular biology and disease, as well as their risk factors including: disturbances of lipid and lipoprotein metabolism, diabetes and hypertension, thrombosis, and inflammation. The Editors are interested in original or review papers dealing with the pathogenesis, environmental, genetic and epigenetic basis, diagnosis or treatment of atherosclerosis and related diseases as well as their risk factors.